Skip to search formSkip to main contentSkip to account menu

FCE 26644

Known as: FCE-26644 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Distamycins
PNU 145156ESuradista

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Accuracy of Digital Surface Models derived from archival aerial photographs. Case study for the Czech Republic.
The archival aerial photographs are widely used for landscape change analysis, settlement identification or georelief… 
Review
2011
Review
2011
Self-assessment and tutor assessment in online language learning materials: InGenio FCE online course and tester
This chapter addresses different modalities of assessment, provides an overview of the assessment processes of the basic skills… 
2007
2007
Assessment of health knowledge and risk factors associated with intestinal helminths in tertiary schools in Abeokuta, Nigeria
A study was carried out on 2,020 students (54% from University of Agriculture, Abeokuta (UNAAB) and 46% from Federal College of… 
2004
2004
Antitumor activity of FCE 26644 a new growth-factor complexing molecule
FCE 26644, or 7,7′-(carbonyl-bis[imino-N-methyl-4, 2 pyrrole carbonyl-imino{N-methyl-4, 2-pyrrole}carbonylimino])-bis-(1, 3… 
1989
1989
In-vitro activity of a new penem FCE 22101.
The in-vitro activity of a new penem FCE 22101 was evaluated in comparison with other antimicrobial agents against 966 aerobic… 
1989
1989
In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis.
Seven strains of viridans streptococci isolated from patients with endocarditis were inhibited in vitro by 0.06-2 mg/l and 0.016… 
1989
1989
Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.
The inhibitory activity of penem FCE 22101 was compared with those of imipenem and other relevant antibiotics against over 500… 
1985
1985
The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
FCE 22101 is a penem antibiotic which inhibits the majority of Enterobacteriaceae, Haemophilus influenzae, and Neisseria… 
1985
1985
Laboratory evaluation of a new long-acting 3-azinomethylrifamycin FCE 22250.
FCE 22250 (3-(N-piperidinomethylazino)methylrifamycin SV) is a member of the new class of 3-azinomethylrifamycins characterized… 
1983
1983
In vitro and in vivo evaluation of the penem FCE 22101 and its orally absorbed ester FCE 22891.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)